{"id":998646,"date":"2026-08-27T16:08:25","date_gmt":"2026-08-27T20:08:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/"},"modified":"2026-08-27T16:08:25","modified_gmt":"2026-08-27T20:08:25","slug":"pulmonx-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"Pulmonx to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">REDWOOD CITY, Calif., Aug.  27, 2026  (GLOBE NEWSWIRE) &#8212; Pulmonx Corporation (Nasdaq: LUNG) (\u201cPulmonx\u201d) a global leader in minimally invasive treatments for severe lung disease, today announced that management will participate in the following upcoming investor conferences:<\/p>\n<p align=\"justify\">\n        <strong>Wells Fargo Healthcare Conference<\/strong><br \/>\n        <br \/>\n        <strong>Format:<\/strong> 1&#215;1 meetings<br \/><strong>Date:<\/strong> Wednesday, September 9<br \/><strong>Location:<\/strong> Boston, MA<\/p>\n<p align=\"justify\">\n        <strong>Lake Street Best Ideas Growth (BIG10) Conference<\/strong><br \/>\n        <br \/>Format: 1&#215;1 meetings<br \/>Date: Thursday, September 10<br \/>Location: New York, NY<\/p>\n<p align=\"justify\">\n        <strong>About Pulmonx Corporation<br \/><\/strong>Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD).\u202fPulmonx\u2019s\u202fZephyr<sup>\u00ae<\/sup> Endobronchial Valve,\u202fChartis<sup>\u00ae<\/sup> Pulmonary Assessment System, LungTraX<sup>\u00ae<\/sup>\u202fPlatform, and\u202fStratX<sup>\u00ae<\/sup> Lung Analysis Reports are designed to assess and treat patients with severe emphysema\/COPD who despite medical management are still profoundly symptomatic. Pulmonx received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) to commercialize the Zephyr<sup>\u00ae<\/sup> Endobronchial Valve following its designation as a \u201cbreakthrough device.\u201d The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option\u202ffor improving breathing,\u202factivity\u202fand quality of life in patients with severe emphysema. For more information on\u202fthe Zephyr\u202fValves and the company, please visit\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YmA7o6ilb4WKdlMT4ioq5HMgdznS4x5rgEoeghktY2vnkXUC2mihtTgfsCO645WwiX4QZknP_4k3Ma8E92d-Fd9vR5c0OaETr9HH1w_h3PWX-WUzMDVQn-aR9eO7pnGVy7DwM-_nmfXXlBWWo0OG4NkHky-SDcJ-tBlrx-sRw0co8P2sP1_DqIEvo7IS_wV9EWzHEaakefZtzddF3ixS6fQ4a5ilRhqIk_tWUoWFyPb8xdEXjSzdnrYl7lug3MGF3sRg-cWsPVp_lsdZVJltZC-4bJhV5kVvmMVyR2FWCEwxLa6IXVTHD9KpVzTZ1BIHiTjinCyBioCMjZrZOGx2j1EUFHl0MxbtcTdNeACkYzvoSJzvAMX0wCnKJnAeLCM3jSsZmPp8qXs0k3huRKEA76382K21U76zpmHU_qPUvXb7ZQxHq6rjgAVP2R415QFfWTN3bQyYqiAI6ykcVsBoFZLVNuOTAmwsjctHK4UuWzRK9oEwuT7Siz7SyaR99bXqUIwKS3PWJQ6kCrhf05emy_CY3SQtyFt9o5giEkJPn-W1MgzptVKmHzN-KhNPiOrM\" rel=\"nofollow\" target=\"_blank\">www.Pulmonx.com<\/a>.<\/p>\n<p align=\"justify\">Pulmonx<sup>\u00ae<\/sup>,\u202fAeriSeal<sup>\u00ae<\/sup>,\u202fChartis<sup>\u00ae<\/sup>, LungTraX<sup>\u00ae<\/sup>,\u202fStratX<sup>\u00ae<\/sup>, and Zephyr<sup>\u00ae<\/sup> are registered\u202ftrademarks of Pulmonx Corporation.\u202f\u00a0<\/p>\n<p align=\"justify\">\n        <strong>Contact<\/strong><br \/>\n        <br \/>Brian Johnston or Webb Campbell<br \/>Gilmartin Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Qw-LN_eZPihLGb901WSTvvZJT5kCcK3iPz6DOkwNbfJQLN7xWu4r82XAxusvqf5yrqHA_2MySbWgUrSTsnvAqk8VKBFTJPjRsA3Kfn1gRP4=\" rel=\"nofollow\" target=\"_blank\">investors@pulmonx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/M2JlNGUxZWQtZWQ5Zi00ZGQ4LWE3NmYtMzA1NTJiZGZiNmYwLTEyMDYxNDItMjAyNi0wOC0yNy1lbg==\/tiny\/Pulmonx-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) &#8212; Pulmonx Corporation (Nasdaq: LUNG) (\u201cPulmonx\u201d) a global leader in minimally invasive treatments for severe lung disease, today announced that management will participate in the following upcoming investor conferences: Wells Fargo Healthcare Conference Format: 1&#215;1 meetingsDate: Wednesday, September 9Location: Boston, MA Lake Street Best Ideas Growth (BIG10) Conference Format: 1&#215;1 meetingsDate: Thursday, September 10Location: New York, NY About Pulmonx CorporationPulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD).\u202fPulmonx\u2019s\u202fZephyr\u00ae Endobronchial Valve,\u202fChartis\u00ae Pulmonary Assessment System, LungTraX\u00ae\u202fPlatform, and\u202fStratX\u00ae Lung Analysis Reports are designed to assess and treat patients with severe emphysema\/COPD who despite medical management are still profoundly symptomatic. Pulmonx received U.S. Food and Drug Administration &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pulmonx to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-998646","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pulmonx to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pulmonx to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) &#8212; Pulmonx Corporation (Nasdaq: LUNG) (\u201cPulmonx\u201d) a global leader in minimally invasive treatments for severe lung disease, today announced that management will participate in the following upcoming investor conferences: Wells Fargo Healthcare Conference Format: 1&#215;1 meetingsDate: Wednesday, September 9Location: Boston, MA Lake Street Best Ideas Growth (BIG10) Conference Format: 1&#215;1 meetingsDate: Thursday, September 10Location: New York, NY About Pulmonx CorporationPulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD).\u202fPulmonx\u2019s\u202fZephyr\u00ae Endobronchial Valve,\u202fChartis\u00ae Pulmonary Assessment System, LungTraX\u00ae\u202fPlatform, and\u202fStratX\u00ae Lung Analysis Reports are designed to assess and treat patients with severe emphysema\/COPD who despite medical management are still profoundly symptomatic. Pulmonx received U.S. Food and Drug Administration &hellip; Continue reading &quot;Pulmonx to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T20:08:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pulmonx to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-08-27T20:08:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":229,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"Pulmonx to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=\",\"datePublished\":\"2026-08-27T20:08:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pulmonx to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pulmonx to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Pulmonx to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) &#8212; Pulmonx Corporation (Nasdaq: LUNG) (\u201cPulmonx\u201d) a global leader in minimally invasive treatments for severe lung disease, today announced that management will participate in the following upcoming investor conferences: Wells Fargo Healthcare Conference Format: 1&#215;1 meetingsDate: Wednesday, September 9Location: Boston, MA Lake Street Best Ideas Growth (BIG10) Conference Format: 1&#215;1 meetingsDate: Thursday, September 10Location: New York, NY About Pulmonx CorporationPulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD).\u202fPulmonx\u2019s\u202fZephyr\u00ae Endobronchial Valve,\u202fChartis\u00ae Pulmonary Assessment System, LungTraX\u00ae\u202fPlatform, and\u202fStratX\u00ae Lung Analysis Reports are designed to assess and treat patients with severe emphysema\/COPD who despite medical management are still profoundly symptomatic. Pulmonx received U.S. Food and Drug Administration &hellip; Continue reading \"Pulmonx to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-27T20:08:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pulmonx to Participate in Upcoming Investor Conferences","datePublished":"2026-08-27T20:08:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/"},"wordCount":229,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/","name":"Pulmonx to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=","datePublished":"2026-08-27T20:08:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNzExMCM3ODA2MDcyIzIxOTQ1ODk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pulmonx to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=998646"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998646\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=998646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=998646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=998646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}